Ticker LaunchSPAC · Searching for a target · ALLR
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. (ALLR) is a blank-check company (SPAC) that completed its initial public offering on Apr 20, 2023, listing on Nasdaq Global Market. It has not announced a definitive business combination agreement. A.G.P. led the IPO. Lewis Brisbois Bisgaard & Smith advised the SPAC and Sullivan & Worcester advised the underwriters on the IPO.
- Status
- Searching for a target
- Ticker
- ALLR
- IPO date
- Apr 20, 2023
- IPO exchange
- Nasdaq Global Market
- IPO underwriters
- A.G.P.
- SPAC counsel (IPO)
- Lewis Brisbois Bisgaard & Smith
- Underwriters' counsel (IPO)
- Sullivan & Worcester
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Apr 20, 2023
- All filings on EDGAR CIK 1860657
Other SPAC IPOs from 2023
- Alchemy Investments Acquisition Corp 1May 5, 2023 · $100M
- Golden Star Acquisition CorpMay 3, 2023 · $60M
- Ares Acquisition Corporation IIApr 24, 2023 · $450M
- TMT Acquisition Corp.Mar 29, 2023 · $60M
- Trailblazer Merger Corp IMar 29, 2023 · $60M
- Oak Woods Acquisition CorporationMar 24, 2023 · $50M